John E Doster | AnMed

Dr. John E. Doster

Claim this profile

AnMed Health Cancer Center

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
19 reported clinical trials
34 drugs studied

Area of expertise

1

Lung Cancer

John E. Doster has run 8 trials for Lung Cancer. Some of their research focus areas include:

Stage III
Stage II
Stage I
2

Non-Small Cell Lung Cancer

John E. Doster has run 6 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

AnMed Health Cancer Center

Clinical Trials John E. Doster is currently running

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Image of trial facility.

Telephone Symptom Monitoring

for Cancer

In this clinical trial, symptom monitoring (interactive voice response \[IVR\] is compared to automated telephone symptom management \[ATSM\] and telephone interpersonal counseling \[TIPC\]) for reducing symptom burden and psychological distress (depressive and anxiety symptoms) among people receiving oral anti-cancer treatment. Symptoms are the number one driver of treatment interruptions and unscheduled health services use. To reduce the risk of these events, symptom monitoring and management are necessary. However, these services are not implemented routinely, especially in the community oncology settings. Further, depressive and anxiety symptoms are a key barrier to enacting symptom self-management strategies. IVR is a form of symptom monitoring where patients, when called, enter their symptom ratings over the phone. Their symptom summary is sent to their provider, and patients may be advised to reach out to their oncology provider, based on their symptoms. The ATSM intervention combines IVR assessments with a Symptom Management and Survivorship educational handbook with self-management strategies. Patients receiving ATSM enter their symptom ratings over the phone and have their symptoms reported to their provider, but patients are also directed to the handbook for strategies to manage elevated symptoms. Patients receiving ATSM who report being anxious, discouraged, or sad will also receive TIPC, which targets psychological distress and its connection to social support and interpersonal communication. Information gathered from this study may help researchers learn more about the best ways to manage patient symptoms and improve patient outcomes.

Recruiting

1 award

N/A

3 criteria

More about John E. Doster

Clinical Trial Related

2 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 6 Active Clinical Trials

Treatments John E. Doster has experience with

  • Biospecimen Collection
  • Gemcitabine Hydrochloride
  • Atezolizumab
  • Oxaliplatin
  • Chemotherapy
  • Docetaxel

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does John E. Doster specialize in?

Is John E. Doster currently recruiting for clinical trials?

Are there any treatments that John E. Doster has studied deeply?

What is the best way to schedule an appointment with John E. Doster?

What is the office address of John E. Doster?

Is there any support for travel costs?